MedTrace Logo

The Prevent Anal Cancer Self-Swab Study

NCT03489707 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 253

Last updated 2024-11-12

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to find ways to screen for anal cancer among gay, bisexual, and other men who have sex with men (MSM) and transgender persons. This study will try to find out if persons will do annual anal cancer screening, what factors are associated with repeated screening, and how this affects a person's decision to have high-resolution anoscopy.

Conditions

Interventions

BEHAVIORAL

Home-based human papillomavirus (HPV) DNA screening

Persons randomized to arm 1 will receive an HPV DNA home-based collection kit in the mail at 0 and 12 months.

BEHAVIORAL

Clinic-based human papillomavirus (HPV) DNA screening

Persons randomized to arm 2 will attend a clinic where a clinician will collect the DNA specimen at 0 and 12 months.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Alan G Nyitray, PhD · Medical College of Wisconsin

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-09
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03489707 on ClinicalTrials.gov